ASRS
MLYS icon

Arizona State Retirement System’s Mineralys Therapeutics MLYS Stock Holding History

Arizona State Retirement System’s Portfolio MLYS Stock Details MLYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$414K Buy
15,357
+2,815
+22% +$77.2K ﹤0.01% 1622
2026
Q1 		$340K Sell
12,542
-458
-4% -$13.4K ﹤0.01% 1665
2025
Q4 		$472K Buy
13,000
+2,393
+23% +$96K ﹤0.01% 1515
2025
Q3 		$402K Buy
+10,607
New +$229K ﹤0.01% 1635

Other funds holding MLYS

CP
Catalys Pacific Tokyo, Japan $229M AUM 100.3% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Arizona State Retirement System's MLYS Position: Q2 2026 in Review

Arizona State Retirement System increased its Mineralys Therapeutics (MLYS) stake by 22% in Q2 2026, buying an estimated $77.2K and bringing the position to 15,357 shares worth $414K. The position accounts for ﹤0.01% of the portfolio, ranked #1622.

Arizona State Retirement System first reported a position in MLYS in Q3 2025 and has held it in 4 quarters since. The position peaked at $472K in Q4 2025. 226 funds tracked by Wall St. Rank hold MLYS as of Q2 2026.

  • Arizona State Retirement System held 15,357 shares of Mineralys Therapeutics worth $414K as of Q2 2026.
  • Arizona State Retirement System bought 2,815 Mineralys Therapeutics shares in Q2 2026, an estimated $77.2K.
  • Mineralys Therapeutics made up ﹤0.01% of Arizona State Retirement System's portfolio in Q2 2026, its #1622 holding.
  • Arizona State Retirement System first reported a position in Mineralys Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • Arizona State Retirement System's Mineralys Therapeutics position peaked at $472K in Q4 2025.
  • 226 funds tracked by Wall St. Rank held Mineralys Therapeutics as of Q2 2026.

Based on Arizona State Retirement System's 13F filing for Q2 2026, filed 7 Aug 2026.